On the public citation graph

Experimental mouse tumour models: what can be learnt about human cancer immunology?

0 signed · 190 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cncr.24429openalex-snapshot
Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer
inferredcites →https://doi.org/10.1016/j.ccr.2010.11.011openalex-snapshot
Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor Progression
inferredcites →https://doi.org/10.1016/j.cell.2010.01.025openalex-snapshot
Immunity, Inflammation, and Cancer
inferredcites →https://doi.org/10.1016/j.cell.2010.03.014openalex-snapshot
Macrophage Diversity Enhances Tumor Progression and Metastasis
inferredcites →https://doi.org/10.1016/j.chom.2009.06.006openalex-snapshot
Humanized Mice for Modeling Human Infectious Disease: Challenges, Progress, and Outlook
inferredcites →https://doi.org/10.1016/j.coi.2004.01.003openalex-snapshot
Animal models of tumor immunity, immunotherapy and cancer vaccines
inferredcites →https://doi.org/10.1016/j.immuni.2010.05.010openalex-snapshot
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
inferredcites →https://doi.org/10.1016/j.vaccine.2007.06.038openalex-snapshot
GSK's antigen-specific cancer immunotherapy programme: Pilot results leading to Phase III clinical development
inferredcites →https://doi.org/10.1016/s0065-2776(06)90005-4openalex-snapshot
Vaccination for Treatment and Prevention of Cancer in Animal Models
inferredcites →https://doi.org/10.1016/s0065-2776(06)90008-xopenalex-snapshot
Checkpoint Blockade in Cancer Immunotherapy
inferredcites →https://doi.org/10.1016/s1074-7613(00)00026-1openalex-snapshot
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
inferredcites →https://doi.org/10.1016/s1074-7613(00)80101-6openalex-snapshot
The Makings of a Tumor Rejection Antigen
inferredcites →https://doi.org/10.1038/184291a0openalex-snapshot
Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse
inferredcites →https://doi.org/10.1038/nature07205openalex-snapshot
Cancer-related inflammation
inferredcites →https://doi.org/10.1038/nature10138openalex-snapshot
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
inferredcites →https://doi.org/10.1038/nm1523openalex-snapshot
Calreticulin exposure dictates the immunogenicity of cancer cell death
inferredcites →https://doi.org/10.1038/nm1622openalex-snapshot
Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
inferredcites →https://doi.org/10.1038/nri1806openalex-snapshot
Regulatory T cells, tumour immunity and immunotherapy
inferredcites →https://doi.org/10.1038/nri1995openalex-snapshot
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
inferredcites →https://doi.org/10.1056/nejmoa020177openalex-snapshot
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
inferredcites →https://doi.org/10.1056/nejmoa1001294openalex-snapshot
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1056/nejmoa1003466openalex-snapshot
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1104621openalex-snapshot
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
inferredcites →https://doi.org/10.1073/pnas.0712237105openalex-snapshot
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
inferredcites →https://doi.org/10.1073/pnas.0806075105openalex-snapshot
CTLA-4 blockade increases IFNγ-producing CD4 + ICOS hi cells to shift the ratio of effector to regulatory T cells in cancer patients
inferredcites →https://doi.org/10.1073/pnas.0813101106openalex-snapshot
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
inferredcites →https://doi.org/10.1073/pnas.1100994108openalex-snapshot
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis
inferredcites →https://doi.org/10.1073/pnas.1104303108openalex-snapshot
Leukocyte composition of human breast cancer
inferredcites →https://doi.org/10.1073/pnas.79.15.4718openalex-snapshot
Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.
inferredcites →https://doi.org/10.1073/pnas.90.8.3539openalex-snapshot
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
inferredcites →https://doi.org/10.1084/jem.190.3.355openalex-snapshot
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
inferredcites →https://doi.org/10.1084/jem.20030590openalex-snapshot
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
inferredcites →https://doi.org/10.1084/jem.20042167openalex-snapshot
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
inferredcites →https://doi.org/10.1084/jem.20091921openalex-snapshot
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
inferredcites →https://doi.org/10.1084/jem.20102131openalex-snapshot
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
inferredcites →https://doi.org/10.1093/jnci/18.6.769openalex-snapshot
Immunity to Methylcholanthrene-Induced Sarcomas
inferredcites →https://doi.org/10.1111/j.0022-202x.2005.23759.xopenalex-snapshot
Bioluminescent Imaging of Melanoma in Live Mice
inferredcites →https://doi.org/10.1126/science.1129139openalex-snapshot
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
inferredcites →https://doi.org/10.1126/science.1203486openalex-snapshot
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
inferredcites →https://doi.org/10.1126/scitranslmed.3002842openalex-snapshot
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
inferredcites →https://doi.org/10.1146/annurev-immunol-031210-101324openalex-snapshot
Natural Innate and Adaptive Immunity to Cancer
inferredcites →https://doi.org/10.1146/annurev.immunol.021908.132544openalex-snapshot
Immune Therapy for Cancer
inferredcites →https://doi.org/10.1146/annurev.immunol.25.022106.141609openalex-snapshot
Immunosuppressive Strategies that are Mediated by Tumor Cells
inferredcites →https://doi.org/10.1146/annurev.immunol.26.021607.090331openalex-snapshot
PD-1 and Its Ligands in Tolerance and Immunity
inferredcites →https://doi.org/10.1158/0008-5472.can-11-1138openalex-snapshot
The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti–CTLA-4 Therapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-07-4079openalex-snapshot
Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1825openalex-snapshot
Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-2931openalex-snapshot
Palettes of Vaccines and Immunostimulatory Monoclonal Antibodies for Combination
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-2487openalex-snapshot
A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-0503openalex-snapshot
Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
inferredcites →https://doi.org/10.1172/jci27745openalex-snapshot
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
inferredcites →https://doi.org/10.1172/jci33522openalex-snapshot
IFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
inferredcites →https://doi.org/10.1172/jci44796openalex-snapshot
A dual role for the immune response in a mouse model of inflammation-associated lung cancer
inferredcites →https://doi.org/10.1200/jco.2009.25.0597openalex-snapshot
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1200/jco.2009.26.7609openalex-snapshot
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
inferredcites →https://doi.org/10.1200/jco.2010.27.9992openalex-snapshot
Dual Roles for Immunity in Gastrointestinal Cancers
inferredcites →https://doi.org/10.4049/jimmunol.165.9.5133openalex-snapshot
DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4891960openalex-extracted
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
inferred← citeshttps://doi.org/10.1002/9781119060727.ch9openalex-snapshot
Nonclinical Pharmacology and Mechanistic Modeling of Antibody–Drug Conjugates in Support of Human Clinical Trials
inferred← citeshttps://doi.org/10.1002/9781119187547.ch15openalex-snapshot
Biomarkers from Bench to Bedside and Back – Back‐Translation of Clinical Studies to Preclinical Models
inferred← citeshttps://doi.org/10.1002/9781119535331.ch1openalex-snapshot
Transplantable Syngeneic Murine Tumor Models
inferred← citeshttps://doi.org/10.1002/9781119535331.ch3openalex-snapshot
Mouse Tumor Homografts Recapitulate Human Molecular Pathogenesis
inferred← citeshttps://doi.org/10.1002/eji.201646632openalex-snapshot
Guidelines for the use of flow cytometry and cell sorting in immunological studies *
inferred← citeshttps://doi.org/10.1002/eji.201970107openalex-snapshot
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
inferred← citeshttps://doi.org/10.1002/eji.202170126openalex-snapshot
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
inferred← citeshttps://doi.org/10.1007/978-1-0716-5037-0_12openalex-snapshot
Advanced Evaluation of T-Cell-Dependent Bispecific Antibodies Using Fluorescence Imaging and In Vivo Models
inferred← citeshttps://doi.org/10.1007/978-981-287-817-5_85openalex-snapshot
Animal Models for Translational Cancer Immunotherapy Studies
inferred← citeshttps://doi.org/10.1007/s00259-016-3560-9openalex-snapshot
Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies
inferred← citeshttps://doi.org/10.1007/s00262-013-1423-9openalex-snapshot
Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy
inferred← citeshttps://doi.org/10.1007/s00262-014-1645-5openalex-snapshot
The importance of comparative oncology in translational medicine
inferred← citeshttps://doi.org/10.1007/s00262-020-02520-zopenalex-snapshot
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
inferred← citeshttps://doi.org/10.1007/s00432-019-02973-5openalex-snapshot
Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux
inferred← citeshttps://doi.org/10.1007/s10439-018-2107-6openalex-snapshot
Improving the Subcutaneous Mouse Tumor Model by Effective Manipulation of Magnetic Nanoparticles-Treated Implanted Cancer Cells
inferred← citeshttps://doi.org/10.1007/s10544-025-00760-3openalex-snapshot
Fabrication of a novel porous silicon biomembrane for applications in organ-on-chip technology
inferred← citeshttps://doi.org/10.1007/s10549-021-06431-0openalex-snapshot
Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
inferred← citeshttps://doi.org/10.1007/s10555-020-09931-5openalex-snapshot
Current methods in translational cancer research
inferred← citeshttps://doi.org/10.1007/s11515-016-1422-2openalex-snapshot
Finding neoepitopes in mouse models of personalized cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s12032-025-02818-xopenalex-snapshot
Tumor microenvironment and immunotherapy: from bench to bedside
inferred← citeshttps://doi.org/10.1016/b978-0-12-394296-8.00007-5openalex-snapshot
Cancer Immunoediting
inferred← citeshttps://doi.org/10.1016/b978-0-12-804310-3.00009-0openalex-snapshot
Evolutionary Perspective of Tumorigenesis and Antitumor Immunity: A Comparative Approach
inferred← citeshttps://doi.org/10.1016/b978-0-12-813886-1.00013-9openalex-snapshot
In vitro models of cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-817134-9.00005-2openalex-snapshot
Discovery and development of ADCs: obstacles and opportunities
inferred← citeshttps://doi.org/10.1016/bs.ai.2015.12.004openalex-snapshot
Mouse Models of Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1016/bs.mcb.2025.02.013openalex-snapshot
In vivo cancer modeling using mouse models
inferred← citeshttps://doi.org/10.1016/bs.mie.2019.05.041openalex-snapshot
Quantitative evaluation of tumor-specific T cells in tumors and lymphoid tissues
inferred← citeshttps://doi.org/10.1016/j.addr.2021.03.001openalex-snapshot
Preclinical models and technologies to advance nanovaccine development
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114821openalex-snapshot
Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics
inferred← citeshttps://doi.org/10.1016/j.apmt.2022.101397openalex-snapshot
Advances in carbon nanomaterials for immunotherapy
inferred← citeshttps://doi.org/10.1016/j.canlet.2016.01.048openalex-snapshot
Animal models of colorectal cancer with liver metastasis
inferred← citeshttps://doi.org/10.1016/j.cell.2016.11.005openalex-snapshot
The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity
inferred← citeshttps://doi.org/10.1016/j.celrep.2015.11.046openalex-snapshot
T Cell Intrinsic USP15 Deficiency Promotes Excessive IFN-γ Production and an Immunosuppressive Tumor Microenvironment in MCA-Induced Fibrosarcoma
inferred← citeshttps://doi.org/10.1016/j.celrep.2015.11.053openalex-snapshot
Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.10.120openalex-snapshot
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development
inferred← citeshttps://doi.org/10.1016/j.coi.2013.02.005openalex-snapshot
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
inferred← citeshttps://doi.org/10.1016/j.coi.2015.05.002openalex-snapshot
New approaches in vaccine-based immunotherapy for human papillomavirus-induced cancer
inferred← citeshttps://doi.org/10.1016/j.gendis.2018.05.003openalex-snapshot
Immunogenic effects of chemotherapy-induced tumor cell death
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e24559openalex-snapshot
Potential role of immunotherapy and targeted therapy in the treatment of cancer: A contemporary nursing practice
inferred← citeshttps://doi.org/10.1016/j.humimm.2016.02.012openalex-snapshot
Mouse models for studies of HLA-G functions in basic science and pre-clinical research
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.125924openalex-snapshot
Immunogenicity of neoantigens: From CAR-T cell to various vaccines
inferred← citeshttps://doi.org/10.1016/j.immuni.2019.12.011openalex-snapshot
Top 10 Challenges in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1016/j.isci.2023.108198openalex-snapshot
Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer
inferred← citeshttps://doi.org/10.1016/j.molonc.2013.02.007openalex-snapshot
Mouse models for studying angiogenesis and lymphangiogenesis in cancer
inferred← citeshttps://doi.org/10.1016/j.omto.2021.12.003openalex-snapshot
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2017.10.018openalex-snapshot
Emerging tumor spheroids technologies for 3D in vitro cancer modeling
inferred← citeshttps://doi.org/10.1016/j.radonc.2024.110424openalex-snapshot
Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors
inferred← citeshttps://doi.org/10.1016/j.semcdb.2021.05.029openalex-snapshot
Interaction of long non-coding RNAs and circular RNAs with microRNAs for the regulation of immunological responses in human cancers
inferred← citeshttps://doi.org/10.1016/j.smim.2016.02.003openalex-snapshot
Neutrophils: Critical components in experimental animal models of cancer
inferred← citeshttps://doi.org/10.1016/j.trecan.2015.12.003openalex-snapshot
Microfluidics: A New Tool for Modeling Cancer–Immune Interactions
inferred← citeshttps://doi.org/10.1016/s1470-2045(12)70051-7openalex-snapshot
Intensifying tumour immunity through combination therapy
inferred← citeshttps://doi.org/10.1021/acsami.3c11098openalex-snapshot
Multimodal Imaging-Guided Strategy for Developing 177 Lu-Labeled Metal–Organic Framework Nanomedicine with Potential in Cancer Therapy
inferred← citeshttps://doi.org/10.1038/cti.2014.18openalex-snapshot
Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies
inferred← citeshttps://doi.org/10.1038/jid.2012.273openalex-snapshot
Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
inferred← citeshttps://doi.org/10.1038/labinvest.2017.8openalex-snapshot
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance
inferred← citeshttps://doi.org/10.1038/nm.3335openalex-snapshot
Immunotherapy at Large: Balancing tumor immunity and inflammatory pathology
inferred← citeshttps://doi.org/10.1038/nm.3397openalex-snapshot
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence
inferred← citeshttps://doi.org/10.1038/nprot.2015.114openalex-snapshot
Using the GEMM-ESC strategy to study gene function in mouse models
inferred← citeshttps://doi.org/10.1038/nprot.2017.130openalex-snapshot
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents
inferred← citeshttps://doi.org/10.1038/nrc.2018.6openalex-snapshot
Using immunotherapy to boost the abscopal effect
inferred← citeshttps://doi.org/10.1038/nrc3237openalex-snapshot
Combining immunotherapy and targeted therapies in cancer treatment
inferred← citeshttps://doi.org/10.1038/s41418-020-00658-yopenalex-snapshot
The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses
inferred← citeshttps://doi.org/10.1038/s41571-018-0046-7openalex-snapshot
Safety of combining radiotherapy with immune-checkpoint inhibition
inferred← citeshttps://doi.org/10.1038/s41577-021-00574-3openalex-snapshot
CD8+ T cell differentiation and dysfunction in cancer
inferred← citeshttps://doi.org/10.1038/s41598-020-65488-xopenalex-snapshot
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model
inferred← citeshttps://doi.org/10.1038/s41598-022-07153-zopenalex-snapshot
Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment
inferred← citeshttps://doi.org/10.1039/c4py00369aopenalex-snapshot
Camptothecin prodrug block copolymer micelles with high drug loading and target specificity
inferred← citeshttps://doi.org/10.1039/c9mh01725aopenalex-snapshot
Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy
inferred← citeshttps://doi.org/10.1080/14728222.2024.2344697openalex-snapshot
Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress
inferred← citeshttps://doi.org/10.1080/19490976.2025.2557978openalex-snapshot
Live biotherapeutic enterococcus lactis MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles
inferred← citeshttps://doi.org/10.1093/ilar/ily014openalex-snapshot
Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research
inferred← citeshttps://doi.org/10.1097/igc.0000000000001053openalex-snapshot
Orientation of Preclinical Research in Ovarian Cancer
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000203openalex-snapshot
Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era
inferred← citeshttps://doi.org/10.1101/2022.02.04.478208openalex-snapshot
Bi-steric mTORC1-selective Inhibitors activate 4EBP1 reversing MYC-induced tumorigenesis and synergize with immunotherapy
inferred← citeshttps://doi.org/10.1101/694232openalex-snapshot
Molecular and cellular phenotypic differences distinguish murine syngeneic models from human tumors
inferred← citeshttps://doi.org/10.1101/cshperspect.a041380openalex-snapshot
Next-Generation Modeling of Cancer Using Organoids
inferred← citeshttps://doi.org/10.1111/ajco.13966openalex-snapshot
Combinatorial approach of immuno‐proton therapy in cancer: Rationale and potential impact
inferred← citeshttps://doi.org/10.1111/imr.13245openalex-snapshot
Toward the clinical development of synthetic immunity to cancer
inferred← citeshttps://doi.org/10.1126/science.aac9935openalex-snapshot
MYC regulates the antitumor immune response through CD47 and PD-L1
inferred← citeshttps://doi.org/10.1146/annurev-cancerbio-070120-094725openalex-snapshot
CRISPR Screens to Identify Regulators of Tumor Immunity
inferred← citeshttps://doi.org/10.1158/0008-5472.can-12-2449openalex-snapshot
Booster Vaccinations against Cancer Are Critical in Prophylactic but Detrimental in Therapeutic Settings
inferred← citeshttps://doi.org/10.1158/2159-8290.cd-13-0452openalex-snapshot
Oncology Drug Discovery: Planning a Turnaround
inferred← citeshttps://doi.org/10.1158/2326-6066.cir-16-0114openalex-snapshot
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
inferred← citeshttps://doi.org/10.1158/2767-9764.crc-21-0126openalex-snapshot
Tumor Purity in Preclinical Mouse Tumor Models
inferred← citeshttps://doi.org/10.11606/t.39.2018.tde-30012018-112604openalex-snapshot
Caquexia do câncer: potencial terapêutico do treinamento físico aeróbio sobre o músculo esquelético
inferred← citeshttps://doi.org/10.1172/jci.insight.182328openalex-snapshot
Flotillin-2 dampens T cell antigen sensitivity and functionality
inferred← citeshttps://doi.org/10.1172/jci68340openalex-snapshot
New cast for a new era: preclinical cancer drug development revisited
inferred← citeshttps://doi.org/10.1186/gm544openalex-snapshot
Transcriptional dissection of pancreatic tumors engrafted in mice
inferred← citeshttps://doi.org/10.1186/s12864-019-6344-3openalex-snapshot
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
inferred← citeshttps://doi.org/10.1186/s12918-015-0168-9openalex-snapshot
CD8 + T cell response to adenovirus vaccination and subsequent suppression of tumor growth: modeling, simulation and analysis
inferred← citeshttps://doi.org/10.1186/s12951-026-04623-8openalex-snapshot
Enhancing antitumor immunity in triple-negative breast cancer through reversal of T-cell exhaustion using a CD8-targeted and membrane-camouflaged nanocarrier delivering small interfering RNA against sorting Nexin 9
inferred← citeshttps://doi.org/10.1186/s40425-017-0218-5openalex-snapshot
Combination immunotherapy: a road map
inferred← citeshttps://doi.org/10.1208/s12248-024-00998-4openalex-snapshot
PK/PD Evaluation of Antibody–Drug Conjugates with Enhanced Immune Effector Functions
inferred← citeshttps://doi.org/10.1364/boe.433754openalex-snapshot
Monitoring subcutaneous tumors using Mueller polarimetry: study on two types of tumors
inferred← citeshttps://doi.org/10.1371/journal.pone.0322876openalex-snapshot
Animal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes
inferred← citeshttps://doi.org/10.1538/expanim.22-0133openalex-snapshot
A fast and simple protocol to anaesthesia in chicken embryos
inferred← citeshttps://doi.org/10.1586/14760584.2013.845530openalex-snapshot
Preclinical vaccines against mammary carcinoma
inferred← citeshttps://doi.org/10.18632/oncotarget.10880openalex-snapshot
Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3351199/v1openalex-snapshot
Comprehensive profiling the immune-status of a broad range of in vivo syngeneic models to support IO development and to accurately predict clinical benefit of therapy
inferred← citeshttps://doi.org/10.21203/rs.3.rs-8902836/v1openalex-snapshot
Comparative Kinetic and Angiogenic Characterization of Syngeneic Heterotopic Murine Tumors by Using B-Mode and Doppler Ultrasonography
inferred← citeshttps://doi.org/10.2139/ssrn.3353223openalex-snapshot
Longitudinal Single Cell Profiling of Regulatory T Cells Identifies IL-33 as a Driver of Tumor Immunosuppression
inferred← citeshttps://doi.org/10.2147/bctt.s490532openalex-snapshot
Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
inferred← citeshttps://doi.org/10.2174/9789815123258123010015openalex-snapshot
Future Path and Perspectives of Immunomodulators
inferred← citeshttps://doi.org/10.23937/ijor-2017/1710008openalex-snapshot
Organoids as Reliable Breast Cancer Study Models: An Update
inferred← citeshttps://doi.org/10.26686/wgtn.17013347openalex-snapshot
Improving immunotherapy for high grade glioma
inferred← citeshttps://doi.org/10.26686/wgtn.17013347.v1openalex-snapshot
Improving immunotherapy for high grade glioma
inferred← citeshttps://doi.org/10.26686/wgtn.17013761openalex-snapshot
Attenuation of Immune Suppression to Complement Glioma Immunotherapy
inferred← citeshttps://doi.org/10.26686/wgtn.17013761.v1openalex-snapshot
Attenuation of Immune Suppression to Complement Glioma Immunotherapy
inferred← citeshttps://doi.org/10.31224/osf.io/mztycopenalex-snapshot
Novel Fabrication Approach of a Porous Silicon Biocompatible Membrane Evaluated within a Alveolar Coculture Model
inferred← citeshttps://doi.org/10.31390/gradschool_dissertations.4669openalex-snapshot
Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1152035openalex-snapshot
Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies
inferred← citeshttps://doi.org/10.3389/fonc.2024.1413793openalex-snapshot
Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
inferred← citeshttps://doi.org/10.3389/fphar.2016.00515openalex-snapshot
Inferring the Impact of Regulatory Mechanisms that Underpin CD8+ T Cell Control of B16 Tumor Growth In vivo Using Mechanistic Models and Simulation
inferred← citeshttps://doi.org/10.3389/fvets.2024.1320696openalex-snapshot
Mammary gland, skin and soft tissue tumors in pet cats: findings of the feline tumors collected from 2002 to 2022
inferred← citeshttps://doi.org/10.3390/cancers11020244openalex-snapshot
Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches
inferred← citeshttps://doi.org/10.3390/cancers11040480openalex-snapshot
Membrane Lipidome Reorganization and Accumulation of Tissue DNA Lesions in Tumor-Bearing Mice: An Exploratory Study
inferred← citeshttps://doi.org/10.3390/cancers12010061openalex-snapshot
ERK Activation Modulates Cancer Stemness and Motility of a Novel Mouse Oral Squamous Cell Carcinoma Cell Line
inferred← citeshttps://doi.org/10.3390/cancers18091412openalex-snapshot
Determinants of Chimeric Antigen Receptor (CAR) T Cell Success: In Vitro and In Vivo Preclinical Assessment
inferred← citeshttps://doi.org/10.3390/vaccines3020467openalex-snapshot
The Promise of Preventive Cancer Vaccines
inferred← citeshttps://doi.org/10.3410/f.718178572.793488231openalex-snapshot
Faculty Opinions recommendation of Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence.
inferred← citeshttps://doi.org/10.37349/emed.2021.00043openalex-snapshot
Emerging nanomaterials for cancer immunotherapy
inferred← citeshttps://doi.org/10.3791/55712openalex-snapshot
Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
inferred← citeshttps://doi.org/10.3791/55712-vopenalex-snapshot
Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
inferred← citeshttps://doi.org/10.3855/jidc.7201openalex-snapshot
Vaccines for tumor prevention: a pipe dream?
inferred← citeshttps://doi.org/10.3920/978-90-8686-834-6_77openalex-snapshot
77. Mouse models: some reflections from the lab
inferred← citeshttps://doi.org/10.4018/978-1-5225-2072-6.ch011openalex-snapshot
Thermography in Animal Models of Cancer
inferred← citeshttps://doi.org/10.4018/978-1-5225-5640-4.ch007openalex-snapshot
Thermography in Animal Models of Cancer
inferred← citeshttps://doi.org/10.4049/jimmunol.1600589openalex-snapshot
Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
inferred← citeshttps://doi.org/10.4161/21645515.2014.982999openalex-snapshot
Regulatory considerations for clinical development of cancer vaccines
inferred← citeshttps://doi.org/10.4161/hv.29679openalex-snapshot
Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer
inferred← citeshttps://doi.org/10.4172/2157-7560.1000324openalex-snapshot
Improving Anti-cancer Immunotherapy by Simultaneous Targeting Suppressive Tumor Microenvironment
inferred← citeshttps://doi.org/10.5772/intechopen.74688openalex-snapshot
Immune Checkpoint Blockade and Immune Monitoring
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.